Загрузка...
Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets
OBJECTIVE: To test the hypothesis that dimethyl fumarate (Tecfidera, BG-12) affects B-cell subsets in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: Peripheral blood B cells were compared for surface marker expression in patients with RRMS prior to initiation of treatment, aft...
Сохранить в:
| Опубликовано в: : | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Lippincott Williams & Wilkins
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4784801/ https://ncbi.nlm.nih.gov/pubmed/27006972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000211 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|